Jounce Therapeutics Inc - Cambridge, Massachusetts 02138

Jounce Therapeutics Inc is categorized under Research and Development Laboratories in Cambridge, MA .

Business Name: Jounce Therapeutics Inc
Contact Person: Cary Pfeffer
Address: 1030 Massachusetts Avenue, Cambridge, Massachusetts 02138
Phone Number: (857) 259-3840
Website Address: jouncetx.com
Annual Revenue (USD): $500.000 to $999.999
Founding Year: 2013
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Research and Development Laboratories
SIC Code: 8731
NAICS Code: 541712
Share This Business:
Related Businesses: Hyperion Catalysis International Inc - Cambridge, MA 02138
Cellendyne - Cambridge, MA 02138
Molecmo Nanobiotechnologies - Cambridge, MA 02138
Cromesett Energy Technologies LLC - Cambridge, MA 02138
Soane Labs LLC - Cambridge, MA 02138
Avogadro Inc - Cambridge, MA 02138
Bnw Technologies - Cambridge, MA 02138
Novobiotic Pharmaceuticals LLC - Cambridge, MA 02138
Cambridge Chemical Techs - Cambridge, MA 02138
Radcliff - Cambridge, MA 02138
Quintiles - Cambridge, MA 02138
Boston Micromachines Corp - Cambridge, MA 02138
Soane Energy LLC - Cambridge, MA 02138
Hstar Technologies Corp - Cambridge, MA 02138

The company Jounce Therapeutics Inc provides B2B services in the form of Research and Development Laboratories from its single location in Massachusetts. 1 to 4 employees work for Jounce Therapeutics Inc, and the business now earns $500.000 to $999.999 per annum.

Jounce Therapeutics Inc was launched in 2013 and is classified under SIC code and category 8731 , and NAICS number and grouping 541712 . To contact Jounce Therapeutics Inc, please call Cary Pfeffer with the phone number (857) 259-3840 or visit its single location at 1030 Massachusetts Avenue in Cambridge, Massachusetts 02138.

The location of the single location can also be found using the coordinates 42.369519,-71.112138. Read more details about this business on the webpage jouncetx.com or follow the company’s social media accounts, on Twitter and on Facebook.